Literature DB >> 9378822

A panel of antibodies for the immunostaining of Bouin's fixed bone marrow trephine biopsies.

J L Gala1, F Chenut, K B Hong, J Rodhain, P Camby, M Philippe, J M Scheiff.   

Abstract

AIMS: To assess a panel of antibodies on Bouin's fixed bone marrow trephine (BMT) biopsies. These biopsies are widely used in routine diagnosis of various haematological malignancies and may be the sole material available in many centres; however, information regarding the immunostaining of this material is lacking.
METHODS: Biopsies were taken from 72 patients presenting with various haematological malignancies (leukaemia, 38; lymphoma, 14; multiple myeloma, 20). A panel of antibodies was assessed on Bouin's fixed BMT biopsies by the alkaline phosphatase-antialkaline phosphatase method.
RESULTS: Three B (MB2, LN-2, Ki-B5) and two T cell lineage antibodies (UCHL-1, CD3-r) reliably identified lymphoid cells, while MPO-r, Leu-M1/CD15, and KP-1/CD68 recognised cells from the myeloid or histiocytic/macrophage series. Reed-Sternberg cells were stained by LN-2, Leu-M1, and CD30. Antibodies specific for plasma cells (VS38) and hairy cells (DBA.44) gave a variable pattern of staining. Among the proliferation markers, proliferative cell nuclear antigen but not Ki-67 related antibodies were effective.
CONCLUSION: This study presents a panel of antibodies with reactivity not restricted to common fixatives that are also suitable for Bouin's fixed BMT biopsies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378822      PMCID: PMC499996          DOI: 10.1136/jcp.50.6.521

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections.

Authors:  G Cattoretti; S Pileri; C Parravicini; M H Becker; S Poggi; C Bifulco; G Key; L D'Amato; E Sabattini; E Feudale
Journal:  J Pathol       Date:  1993-10       Impact factor: 7.996

2.  Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue.

Authors:  V L Kubic; R D Brunning
Journal:  Mod Pathol       Date:  1989-11       Impact factor: 7.842

Review 3.  Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues.

Authors:  S L Perkins; C R Kjeldsberg
Journal:  Am J Clin Pathol       Date:  1993-04       Impact factor: 2.493

4.  Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens.

Authors:  H P Horny; M Wehrmann; H Griesser; M Tiemann; B Bültmann; E Kaiserling
Journal:  Am J Clin Pathol       Date:  1993-02       Impact factor: 2.493

5.  Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections.

Authors:  M L Hansmann; H H Wacker; J Gralla; H Lumbeck; M Kossmahl; H J Heidebrecht; H J Radzun; M R Parwaresch
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

6.  Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.

Authors:  D Hakimian; M S Tallman; C Kiley; L Peterson
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

7.  Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations.

Authors:  P J Kurtin; P C Roche
Journal:  Am J Surg Pathol       Date:  1993-09       Impact factor: 6.394

8.  VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections.

Authors:  H Turley; M Jones; W Erber; K Mayne; M de Waele; K Gatter
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

9.  Use of APAAP technique on paraffin wax embedded bone marrow trephines.

Authors:  W N Erber; J McLachlan
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

10.  High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis.

Authors:  J L Gala; C Vermylen; G Cornu; A Ferrant; J L Michaux; M Philippe; P Martiat
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

View more
  7 in total

1.  L26 (CD20) staining of Bouin fixed bone marrow biopsies.

Authors:  D S O'Briain; C Murphy
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Bouin's fixed trephine biopsies.

Authors:  G M Markey; H D Alexander; H Foster
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

3.  How we process trephine biopsy specimens: epoxy resin embedded bone marrow biopsies.

Authors:  T Krenacs; E Bagdi; E Stelkovics; L Bereczki; L Krenacs
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

4.  Antibody panel in diagnosis of lymphoid neoplasms.

Authors:  J Vassallo; G A Pinto
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 5.  Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol.

Authors:  K N Naresh; I Lampert; R Hasserjian; D Lykidis; K Elderfield; D Horncastle; N Smith; W Murray-Brown; G W Stamp
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

6.  Immunohistochemical assays in prostatic biopsies processed in Bouin's fixative.

Authors:  V Ananthanarayanan; M R Pins; R E Meyer; P H Gann
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

7.  Picrosirius Red Staining: Revisiting Its Application to the Qualitative and Quantitative Assessment of Collagen Type I and Type III in Tendon.

Authors:  Consuelo M López De Padilla; Michael J Coenen; Alejandro Tovar; Rodolfo E De la Vega; Christopher H Evans; Sebastian A Müller
Journal:  J Histochem Cytochem       Date:  2021-09-22       Impact factor: 4.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.